Biosig Capital Surpluse vs Warrants Analysis
BSGM Stock | USD 2.01 0.02 0.99% |
Biosig Technologies financial indicator trend analysis is way more than just evaluating Biosig Technologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biosig Technologies is a good investment. Please check the relationship between Biosig Technologies Capital Surpluse and its Warrants accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.
Capital Surpluse vs Warrants
Capital Surpluse vs Warrants Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biosig Technologies Capital Surpluse account and Warrants. At this time, the significance of the direction appears to have pay attention.
The correlation between Biosig Technologies' Capital Surpluse and Warrants is -0.86. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Warrants in the same time period over historical financial statements of Biosig Technologies, assuming nothing else is changed. The correlation between historical values of Biosig Technologies' Capital Surpluse and Warrants is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of Biosig Technologies are associated (or correlated) with its Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Warrants has no effect on the direction of Capital Surpluse i.e., Biosig Technologies' Capital Surpluse and Warrants go up and down completely randomly.
Correlation Coefficient | -0.86 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Capital Surpluse
Warrants
Securities that give the holder the right to purchase a company's stock at a specified price before a certain date. Warrants are similar to options but are typically issued directly by the company.Most indicators from Biosig Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biosig Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.At this time, Biosig Technologies' Issuance Of Capital Stock is very stable compared to the past year. As of the 1st of June 2024, Sales General And Administrative To Revenue is likely to grow to 1,346, while Enterprise Value Over EBITDA is likely to drop (1.31).
2023 | 2024 (projected) | Extraordinary Items | 2.9M | 2.6M | Reconciled Depreciation | 361K | 232.6K |
Biosig Technologies fundamental ratios Correlations
Click cells to compare fundamentals
Biosig Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biosig Technologies fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 14.2M | 30.4M | 15.5M | 4.1M | 1.8M | 1.7M | |
Other Current Liab | 1.6M | 4.8M | 2.3M | 2.9M | 4.2M | 3.0M | |
Total Current Liabilities | 2.0M | 5.1M | 2.6M | 3.3M | 4.6M | 3.2M | |
Total Stockholder Equity | 11.4M | 24.5M | 12.3M | 418K | (2.9M) | (2.8M) | |
Property Plant And Equipment Net | 894.7K | 595.0K | 1.3M | 1.5M | 938K | 531.7K | |
Net Debt | (11.4M) | (28.0M) | (11.0M) | 408K | 262K | 275.1K | |
Retained Earnings | (104.8M) | (157.0M) | (188.9M) | (216.0M) | (245.0M) | (232.8M) | |
Cash | 12.1M | 28.3M | 11.7M | 357K | 190K | 180.5K | |
Non Current Assets Total | 1.4M | 1.0M | 1.6M | 3.0M | 1.3M | 890.5K | |
Non Currrent Assets Other | 129.2K | 107K | 42K | 1.2M | 43K | 40.9K | |
Cash And Short Term Investments | 12.1M | 28.3M | 11.7M | 458K | 293K | 278.4K | |
Common Stock Total Equity | 29.3K | 16.9K | 23.3K | 31K | 35.7K | 21.9K | |
Common Stock Shares Outstanding | 2.1M | 2.8M | 3.4M | 4.3M | 7.4M | 7.7M | |
Liabilities And Stockholders Equity | 14.2M | 30.4M | 15.5M | 4.1M | 1.8M | 1.7M | |
Other Stockholder Equity | 115.9M | 181.3M | 201.1M | 216.2M | 242.1M | 254.2M | |
Total Liab | 2.3M | 5.1M | 3.0M | 3.7M | 4.7M | 3.4M | |
Property Plant And Equipment Gross | 894.7K | 595.0K | 1.8M | 2.4M | 2.5M | 2.6M | |
Total Current Assets | 12.8M | 29.3M | 13.9M | 1.1M | 528K | 501.6K | |
Common Stock | 23.3K | 31K | 36K | 55K | 9K | 8.6K | |
Net Tangible Assets | 3.1M | 10.8M | 24.0M | 11.9M | 13.7M | 14.4M | |
Warrants | 985K | 475K | 215K | 105K | 94.5K | 89.8K | |
Accounts Payable | 346.2K | 30K | 1K | 2.9K | 2.6K | 2.4K | |
Other Assets | 54.2K | 129K | (44.0) | 42K | 48.3K | 44.3K | |
Retained Earnings Total Equity | (56.5M) | (70.7M) | (104.8M) | (157.0M) | (141.3M) | (134.2M) | |
Capital Surpluse | 53.2M | 74.0M | 115.9M | 181.3M | 208.5M | 219.0M | |
Other Current Assets | 141.2K | 301K | 354K | 325.0 | 314K | 181.2K | |
Property Plant Equipment | 44.3K | 894K | 595K | 1.3M | 1.4M | 1.5M | |
Non Current Liabilities Total | 311.1K | 1K | 378K | 452K | 103K | 175.3K | |
Net Invested Capital | 11.1M | 24.4M | 12.2M | 313K | (3.0M) | (2.9M) | |
Net Working Capital | 10.8M | 24.2M | 11.3M | (2.1M) | (4.1M) | (3.9M) | |
Capital Stock | 238.3K | 136K | 141K | 160K | 114K | 170.8K | |
Intangible Assets | 365.7K | 347K | 327K | 308K | 289K | 254.2K |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Biosig Technologies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.Note that the Biosig Technologies information on this page should be used as a complementary analysis to other Biosig Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Biosig Stock analysis
When running Biosig Technologies' price analysis, check to measure Biosig Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosig Technologies is operating at the current time. Most of Biosig Technologies' value examination focuses on studying past and present price action to predict the probability of Biosig Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosig Technologies' price. Additionally, you may evaluate how the addition of Biosig Technologies to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Biosig Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biosig Technologies. If investors know Biosig will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biosig Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.12) | Revenue Per Share 0.003 | Quarterly Revenue Growth 1.8 | Return On Assets (4.48) | Return On Equity (59.77) |
The market value of Biosig Technologies is measured differently than its book value, which is the value of Biosig that is recorded on the company's balance sheet. Investors also form their own opinion of Biosig Technologies' value that differs from its market value or its book value, called intrinsic value, which is Biosig Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biosig Technologies' market value can be influenced by many factors that don't directly affect Biosig Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biosig Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biosig Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biosig Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.